rapamycin and

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

C40-, C28-, AND C-32-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS
EP 4234031 A3Applicant: REVOLUTION MEDICINES INCPriority: 2018
CN
EP
US
WO
15 publications
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
EP 3025713 A1Applicant: SANTEN PHARMACEUTICAL CO LTDPriority: 2005
EP
US
13 publications
O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
US 2008182867 A9Applicant: UNIV PENNSYLVANIAPriority: 2002
US
11 publications
Rapamycin analogues and uses thereof in the treatment of neurological disorders
US 7276498 B2Applicant: WYETH CORPPriority: 2005
CN
US
10 publications
PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCIN
EP 4051241 A4Applicant: ABRAXIS BIOSCIENCE LLCPriority: 2019
CN
EP
US
WO
6 publications
NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
- EP 3417859 A1
  Applicant: ABRAXIS BIOSCIENCE LLCPriority: 2007
  EP
  US
  6 publications
- CN 101730526 A
  Applicant: ABRAXIS BIOSCIENCE LLCPriority: 2008
  CN
Deuterated rapamycin compounds, method and uses thereof
US 6939878 B2Applicant: ISOTECHNIKA INTERNAT INCPriority: 2001
US
6 publications
Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
US 10765665 B2Applicant: MELIN JEFFREYPriority: 2016
US
6 publications
ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF
EP 3947392 B1Applicant: NOVARTIS AGPriority: 2019
CN
EP
US
WO
5 publications
EXTERNAL PREPARATION CONTAINING RAPAMYCIN
EP 4094761 A4Applicant: NOBELPHARMA CO LTDPriority: 2020
CN
EP
US
WO
5 publications

Drugs

rapamycin and

Patents

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT